1. Home
  2. NEXA vs AVDL Comparison

NEXA vs AVDL Comparison

Compare NEXA & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nexa Resources S.A.

NEXA

Nexa Resources S.A.

N/A

Current Price

$7.66

Market Cap

741.7M

ML Signal

N/A

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

N/A

Current Price

$21.42

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NEXA
AVDL
Founded
1956
2015
Country
Luxembourg
Ireland
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
741.7M
2.1B
IPO Year
2017
1996

Fundamental Metrics

Financial Performance
Metric
NEXA
AVDL
Price
$7.66
$21.42
Analyst Decision
Hold
Buy
Analyst Count
5
9
Target Price
$6.20
$18.38
AVG Volume (30 Days)
376.0K
2.1M
Earning Date
10-30-2025
11-04-2025
Dividend Yield
1.32%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,839,970,000.00
$248,517,000.00
Revenue This Year
$3.85
$65.47
Revenue Next Year
$1.53
$30.88
P/E Ratio
N/A
N/A
Revenue Growth
6.95
79.88
52 Week Low
$4.44
$6.38
52 Week High
$9.61
$23.57

Technical Indicators

Market Signals
Indicator
NEXA
AVDL
Relative Strength Index (RSI) 64.27 59.08
Support Level $7.57 $21.36
Resistance Level $8.44 $21.45
Average True Range (ATR) 0.38 0.11
MACD 0.00 -0.21
Stochastic Oscillator 54.44 40.30

Price Performance

Historical Comparison
NEXA
AVDL

About NEXA Nexa Resources S.A.

Nexa Resources SA is a low-cost integrated zinc producer. It produces copper, silver, and gold as byproducts. The company operates through two segments namely Mining and Smelting. Its Mining segment consists of various operating units includes mineral exploration activities and the production of zinc concentrates, copper concentrates and concentrates. The Smelting segment comprises operating units which include facilities recovering and refining zinc metal out of feed materials such as zinc concentrates or secondary feed materials. It generates maximum revenue from the Smelting segment. Geographically It has a presence in Brazil, Peru, the United States of America, Switzerland, Japan, Argentina, South Korea, Colombia, Vietnam, Malaysia and other countries.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: